Topic: Astrazeneca Group
AZN) was cut by some $10 billion dollars following a string of bad press including news that Teva Pharmaceuticals (Nasdaq: TEVA) will soon be selling a generic version of their pediatric asthma drug Pulmicort Respules following a favorable ruling from the FDA ...
AZN) was cut by some $10 billion dollars following a string of bad press including news that Teva Pharmaceuticals (Nasdaq: TEVA) will soon be selling a generic version of their pediatric asthma drug Pulmicort Respules following a favorable ruling from the FDA ...
A new open-label study evaluated patient satisfaction with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy, as measured by the Asthma Treatment Satisfaction Measure (ATSM)(1). Results showed that patients receiving budesonide/formoterol combination therapy administered as adjustable dosage reported significantly greater satisfaction on the ...
4/13/2007 Print E-mail During May, adults and children across the United States can get checked for asthma during the 11th annual Nationwide Asthma Screening Program, sponsored by the American College of Allergy, Asthma & Immunology.. During a screening, adults complete a 20-question ...